Abstract
Traditional Chinese Medicine (TCM) represents thousands of years in treatment protocols for health, healing, and longevity and has evolved into a complex healthcare system. The following chapter is designed to give a basic concise overview of TCM principles and practices, in relation to clinical pharmacology, and focuses on mutually relevant areas of interest. Much as society learned to harness electrical currents to empower machinery, TCM theories of energetic patterns help to empower the functionality of the human body. The major theories include the vital life force, known as Qi, Yin and Yang, Five Elements, herbal medicine, multivariate diagnostics, syndrome differentiation, and acupuncture, among others. In TCM, there is a direct relationship to the energy of nature and the energetic patterns within the human body and the human consciousness. This comprehensive approach is gaining momentum in clinical and network pharmacology, as new technologies emerge regarding TCM collaborative compounds versus singular chemical constituents in treatment modalities. Of major importance to clinical pharmacology are recent TCM evidenced-based empirical studies, correlations, and interactions between herbs and pharmaceuticals, updated data on toxicity, adverse reactions, quality assurance, and herbal medicine standardization. Global concerns over antimicrobial resistance to drugs have put a spotlight on TCM herbal medicines as alternatives with greatly reduced resistance factors. From ancient archives to the Nobel Prize to a formal endorsement by the World Health Organization as a global healthcare system, TCM has widened the lens of modern science. It offers the wisdom and experience of millennia to inspire the think tank of today’s medicine and pharmacology and tomorrow’s generations of integrative healthcare advancements.
Similar content being viewed by others
References and Further Reading
Afshin A et al (2019) Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 393:1958–1972
Appari M et al (2014) Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. Int J Oncol 45:1391–1400
Bensky D (2015) Chinese herbal medicine: materia medica, 3rd edn. Eastland Press, Seattle
Boh B et al (2007) Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13:265–301
Chen CJ, et al. (2008) Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication, J Ethnopharmacol Oct 30;120(1):108–11
Chen CY (2011) TCM database@Taiwan: the world’s largest traditional Chinese medicine database for drug screening in silico. PLoS One 6:e15939. https://doi.org/10.1371/journal.pone.0015939
Chen JK, Chen TT (2004) Chinese medical herbology & pharmacology. Art of Medicine Press, City of Industry
Chen, JK (2020) How COVID-19 (2019-nCoV) is Currently Treated in China with TCM, https://www.elotus.org/article/how-covid-19-2019-ncov-currently-treated-china-tcm
Cragg GM, Newman DJ, Snader KM (1997) Natural products in drug discovery and development. J Nat Prod 60:52–60
Dillon J (2007) From the potion to the pill. Yale Medicine. https://medicine.yale.edu/news/yale-medicine-magazine/from-the-potion-to-the-pill/
Duke-Margolis, Center for Health Policy, FDA (2018) Identifying the root causes of drug shortages and finding enduring solutions. Duke University and FDA Presentation, Washington, DC. https://healthpolicy.duke.edu/sites/default/files/atoms/files/dukefda_drug_shortages_presentation_slides__0.pdf
Eban K (2019) Bottle of lies: the inside story of the generic drug boom. Harper Collins, New York
Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177
Fabricant DS, Farnsworth NR (2001) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109(Suppl 1):69–75
Fan X et al (2011) Network toxicology and its application to traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 36:2920–2922
Fan AY et al (2017) Acupuncture’s role in solving the opioid epidemic: evidence, cost-effectiveness, and care availability for acupuncture as a primary, non-pharmacologic method for pain relief and management. J Integr Med 15(6):411–425. https://doi.org/10.1016/S2095-4964(17)60378-9
Hamburger M, Hostettmann K (1989) Analytical aspects of drugs of natural origin. J Pharm Biomed Anal 7:1337–1349
He LS et al (2016) Administration of traditional chinese blood circulation activating drugs for microvascular complications in patients with type 2 diabetes mellitus. J Doabetes Res 2016:1081657
Ideker T et al (2001) A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2:343–372
Jia DD (1979) Concise history of Chinese medicine (Zhong Guo Yi Xue Shi Lue). Shanxi People’s Press, Taoyuan
Jiang WY (2005) Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 26:558–563
Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711–715
Lei X et al (2015) Liver damage associated with Polygonum multiflorum Thunb.: a systematic review of case reports and case series. Evid Based Complement Alternat Med 2015:459749. Epub 2015 Jan 12. Review
Li S, Zhang B (2013) Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11:110–120
Li S et al (2011) Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst Biol 5(Suppl 1):S10
Li QY et al (2013) Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med 2013:1–9
Li S et al (2014) Network pharmacology in traditional Chinese medicine. Evid Based Complement Alternat Med 2014:138460
Liang X et al (2014) A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol BioSyst 10:1014–1022
Light D (2014) New prescription drugs: a major health risk with few offsetting advantages new prescription drugs: Harvard-Edmond J. Safra Center for Ethics. https://ethics.harvard.edu/blog/new-prescription-drugs-major-health-risk-few-offsetting-advantages
Liu XF, et al (2010) PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach, Nucleic Acids Research, Nucleic Acids Research, 38(suppl_2):W609–W614.
Liu L et al (2014) Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Int J Cancer 134:2489–2503
Ma Y et al (2019) Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. https://onlinelibrary.wiley.com. 24 May 2019
Maciocia G (2015) The foundations of Chinese medicine, 3rd edn. Hardcover, Churchill Livingstone, London. ISBN 9780702052163
McCulloch M, Marshall AC, Nachat A (2018) Modern thoracic oncology, vol 1. World Scientific, New Jersey, pp 261–267
McDonald J, Janz S (2017) Acupuncture evidence project: a comparative literature review. Australian Acupuncture and Chinese Medicine Association, Brisbane, p 181. http://www.acupuncture.org.au/OURSERVICES/Publications/AcupunctureEvidenceProject.aspx
Rates SMK (2001) Plants as source of drugs. Toxicon 39:603–613
Sperber G, Flaws B (2007) Integrated pharmacology: combining modern pharmacology with Chinese medicine. Blue Poppy Press, Boulder
Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10(7):507–519
Veeresham C (2012) Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res 3(4):200–201
WHO (2002) Acupuncture: review and analysis of reports on controlled clinical trials. WHO, Geneva
WHO (2004) SARS: Clinical trials on treatment using a combination of Traditional Chinese Medicine and Western Medicine. http://apps.who.int/medicinedocs/en/d/Js6170e/4.html
WHO (2014) WHO traditional medicine strategy 2014–2023. World Health Organization. https://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/
WHO (2018) Newsroom health topics. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cancer
Williamson E et al (1996) Selection, preparation and pharmacological evaluation of plant material. Wiley, Chichester
Wright CW et al (2010) Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of Qing Hao with potent antimalarial activity. Molecules 15(2):804–812
Xiang Y et al (2019) Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med 8:1958–1975. Published by Wiley
Yi F et al (2018) In silico approach in reveal traditional medicine plants pharmacological material basis. Chin Med 13:33
Zeng ZP Jiang JG (2010) Analysis of the adverse reactions induced by natural product-derived drugs. Br J Pharmacol 159(7):1374–1391
Zhang R et al (2017) TCM-Mesh: the database and analytical system for network pharmacology analysis for TCM preparations. Sci Rep 7:2821
Zhang R et al (2019) Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol 10:123
Zhou X et al (2019) Current status and major challenges to the safety and efficacy presented by Chinese Herbal Medicine. Medicines (Basel) 6(1):1
Acknowledgments
The author wishes to extend her most sincere and heartfelt appreciation to Contributing Editor, Lorna Zilba, MA and the following persons who have graciously shared their time and expertise in reviewing this chapter and offering valuable commentary:
John K. Chen, PhD, Pharm D., OMD, LAc
Elizabeth Chen Christenson, MD, LAc
Edward B. Christenson, MD, Dipl.ABA
Cheryl Schwartz, DVM
Robert M. Grant, MA
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Marshall, A.C. (2019). Traditional Chinese Medicine and Clinical Pharmacology. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_60-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_60-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
Traditional Chinese Medicine and Clinical Pharmacology- Published:
- 04 March 2021
DOI: https://doi.org/10.1007/978-3-319-56637-5_60-2
-
Original
Traditional Chinese Medicine and Clinical Pharmacology- Published:
- 21 May 2020
DOI: https://doi.org/10.1007/978-3-319-56637-5_60-1